/People

Jim Allison, Ph.D.

Investor

Scientific Advisor at Time BioVentures

Find your path to Jim

15 people in our graph can introduce you to Jim.

Each arrow is one introduction. Sign up to fill in the first one.

Ask D.A. Wallach to introduce you to Jim

You →D.A. · together at Time BioVentures →Jim

Ask Jamie Chen to introduce you to Jim

You →Jamie · 11 people · together at Time BioVentures →Jim

Sign up to find every way you can get introduced to Jim

  • Your email: the people you already email who know Jim
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Jim
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

About

Dr. James Allison is Regental Professor and Chair of the Department of Immunology at MD Anderson Cancer Center, where he also directs the Parker Institute for Cancer Research and serves as Executive Director of the Immunotherapy Platform. His research centers on the regulation of T cell responses and cancer immunotherapy, including work on the T cell receptor structure, CD28 costimulation, and CTLA-4 blockade that led to the development of ipilimumab. He received the 2018 Nobel Prize in Physiology or Medicine, shared with Dr. Tasuku Honjo, and the 2015 Lasker-DeBakey Clinical Medical Research Award, and is a member of the National Academies of Science and Medicine.

Invests in

Biotech

Colleagues at Time BioVentures

Frequently asked questions

Who is Jim Allison, Ph.D.?
Dr. James Allison is Regental Professor and Chair of the Department of Immunology at MD Anderson Cancer Center, where he also directs the Parker Institute for Cancer Research and serves as Executive Director of the Immunotherapy Platform. His research centers on the regulation of T cell responses and cancer immunotherapy, including work on the T cell receptor structure, CD28 costimulation, and CTLA-4 blockade that led to the development of ipilimumab. He received the 2018 Nobel Prize in Physiology or Medicine, shared with Dr. Tasuku Honjo, and the 2015 Lasker-DeBakey Clinical Medical Research Award, and is a member of the National Academies of Science and Medicine.
Where does Jim Allison, Ph.D. work?
Jim Allison, Ph.D. is Scientific Advisor at Time BioVentures.
What does Jim Allison, Ph.D. invest in?
Jim Allison, Ph.D. invests in Biotech.